Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice

Human Molecular Genetics

Volumn 21, Issue 20, 2012, Pages 4448-4459

  Bricceno, Katherine V ^a,b   Sampognaro, Paul J ^c   Van meerbeke, James P ^c   Sumner, Charlotte J ^c   Fischbeck, Kenneth H ^a   Burnett, Barrington G ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; DEXAMETHASONE; DIMETHYL SULFOXIDE; HISTONE DEACETYLASE 4; MUSCLE RING FINGER 1 PROTEIN; MYOGENIN; TRICHOSTATIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROGENE; DENERVATION; DISEASE COURSE; ENZYME INHIBITION; GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; UPREGULATION;

ANIMALS; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; MICE; MICE, INBRED STRAINS; MUSCLE PROTEINS; MUSCULAR ATROPHY, SPINAL; MYOGENIN; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN-PROTEIN LIGASES;

MUS;

EID: 84867132241     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds286     Document Type: Article

References (45)

1. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification of spinal muscular atrophy-determining gene. Cell, 80, 155-165.
2. Monani, U.R., Lorson, C.L., Parsons, D.W., Prior, T.W., Androphy, E.J., Burghes, A.H. and McPherson, J.D. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet., 8, 1177-1183.
3. Lorson, C.L., Hahnen, E., Androphy, E.J. and Wirth, B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. U S A, 96, 6307-6311.
4. Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H. and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet., 24, 66-70.
5. Le, T.T., Coovert, D.D., Monani, U.R., Morris, G.E. and Burghes, A.H. (2000) The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization. Neurogenetics, 3, 7-16.
6. Prior, T.W., Swoboda, K.J., Scott, H.D. and Hejmanowski, A.Q. (2004) Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am. J. Med. Genet. A, 130A, 307-310.
7. Le, T.T., Pham, L.T., Butchbach, M.E., Zhang, H.L., Monani, U.R., Coovert, D.D., Gavrilina, T.O., Xing, L., Bassell, G.J. and Burghes, A.H. (2005) SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet., 14, 845-857.
8. Avila, A.M., Burnett, B.G., Taye, A.A., Gabanella, F., Knight, M.A., Hartenstein, P., Cizman, Z., Di Prospero, N.A., Pellizzoni, L., Fischbeck, K.H. et al. (2007) Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest., 117, 659-671.
9. Yoo, Y.E. and Ko, C.P. (2011) Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol., 231, 147-159.
10. Kwon, D.Y., Motley, W.W., Fischbeck, K.H. and Burnett, B.G. (2011) Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice. Hum. Mol. Genet., 20, 3667-3677.
11. Narver, H.L., Kong, L., Burnett, B.G., Choe, D.W., Bosch-Marce, M., Taye, A.A., Eckhaus, M.A. and Sumner, C.J. (2008) Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann. Neurol., 64, 465-470.
12. Lecker, S.H., Solomon, V., Mitch, W.E. and Goldberg, A.L. (1999) Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr., 129, 227S-237S.
13. Tischler, M.E., Rosenberg, S., Satarug, S., Henriksen, E.J., Kirby, C.R., Tome, M. and Chase, P. (1990) Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle. Metabolism, 39, 756-763.
14. Solomon, V., Baracos, V., Sarraf, P. and Goldberg, A.L. (1998) Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. Proc. Natl Acad. Sci. U S A., 95, 12602-12607.
15. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K. et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294, 1704-1708.
16. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H. and Goldberg, A.L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117, 399-412.
17. Stitt, T.N., Drujan, D., Clarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., Gonzalez, M., Yancopoulos, G.D. and Glass, D.J. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell, 14, 395-403.
18. Cai, D., Frantz, J.D., Tawa, N.E. Jr., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J. et al. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell, 119, 285-298.
19. Tang, H., Macpherson, P., Marvin, M., Meadows, E., Klein, W.H., Yang, X.J. and Goldman, D. (2009) A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol. Biol. Cell, 20, 1120-1131.
20. Tang, H. and Goldman, D. (2006) Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade. Proc. Natl Acad. Sci. U S A, 103, 16977-16982.
21. Hasty, P., Bradley, A., Morris, J.H., Edmondson, D.G., Venuti, J.M., Olson, E.N. and Klein, W.H. (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature, 364, 501-506.
22. Moresi, V., Williams, A.H., Meadows, E., Flynn, J.M., Potthoff, M.J., McAnally, J., Shelton, J.M., Backs, J., Klein, W.H., Richardson, J.A. et al. (2010) Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell, 143, 35-45.
23. Macpherson, P.C., Wang, X. and Goldman, D. (2011) Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle. J. Cell Biochem., 112, 2149-2159.
24. Kong, L., Wang, X., Choe, D.W., Polley, M., Burnett, B.G., Bosch-Marce, M., Griffin, J.W., Rich, M.M. and Sumner, C.J. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci., 29, 842-851.
25. Lee, Y.I., Mikesh, M., Smith, I., Rimer, M. and Thompson, W. (2011) Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons. Dev. Biol., 356, 432-444.
26. Baehr, L.M., Furlow, J.D. and Bodine, S.C. (2011) Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J. Physiol., 589, 4759-4776.
27. Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S.J., Di Lisi, R., Sandri, C., Zhao, J. et al. (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab., 6, 458-471.
28. Rudnicki, M.A., Le Grand, F., McKinnell, I. and Kuang, S. (2008) The molecular regulation of muscle stem cell function. Cold Spring Harb. Symp. Quant. Biol., 73, 323-331.
29. Hagiwara, H., Saito, F., Masaki, T., Ikeda, M., Nakamura-Ohkuma, A., Shimizu, T. and Matsumura, K. (2011) Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. Biochem. Biophys. Res. Commun., 414, 826-831.
30. Bowerman, M., Swoboda, K.J., Michalski, J.-P., Wang, G.-S., Reeks, C., Beauvais, A., Murphy, K., Woulfe, J., Screaton, R.A., Scott, F.W. et al. (2012) Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol., doi: 10.1002/ana.23582. [Epub ahead of print].
31. Butchbach, M.E., Rose, F.F. Jr., Rhoades, S., Marston, J., McCrone, J.T., Sinnott, R. and Lorson, C.L. (2010) Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy. Biochem. Biophys. Res. Commun., 391, 835-840.
32. Ling, K.K., Gibbs, R.M., Feng, Z. and Ko, C.P. (2012) Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum. Mol. Genet., 21, 185-195.
33. Kariya, S., Park, G.H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M.S., Landmesser, L.T. and Monani, U.R. (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 2552-2569.
34. Mentis, G.Z., Blivis, D., Liu, W., Drobac, E., Crowder, M.E., Kong, L., Alvarez, F.J., Sumner, C.J. and O'Donovan, M.J. (2011) Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron, 69, 453-467.
35. Clarke, B.A., Drujan, D., Willis, M.S., Murphy, L.O., Corpina, R.A., Burova, E., Rakhilin, S.V., Stitt, T.N., Patterson, C., Latres, E. et al. (2007) The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab., 6, 376-385.
36. Cohen, S., Brault, J.J., Gygi, S.P., Glass, D.J., Valenzuela, D.M., Gartner, C., Latres, E. and Goldberg, A.L. (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J. Cell Biol., 185, 1083-1095.
37. Koyama, S., Hata, S., Witt, C.C., Ono, Y., Lerche, S., Ojima, K., Chiba, T., Doi, N., Kitamura, F., Tanaka, K. et al. (2008) Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J. Mol. Biol., 376, 1224-1236.
38. Mearini, G., Gedicke, C., Schlossarek, S., Witt, C.C., Kramer, E., Cao, P., Gomes, M.D., Lecker, S.H., Labeit, S., Willis, M.S. et al. (2010) Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc. Res., 85, 357-366.
39. Witt, S.H., Granzier, H., Witt, C.C. and Labeit, S. (2005) MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol., 350, 713-722.
40. Millino, C., Fanin, M., Vettori, A., Laveder, P., Mostacciuolo, M.L., Angelini, C. and Lanfranchi, G. (2009) Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med., 7, 14.
41. Rindt, H., Buckley, D.M., Vale, S.M., Krogman, M., Rose, F.F. Jr., Garcia, M.L. and Lorson, C.L. (2012) Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy. Neuromuscul. Disord., 22, 277-285.
42. Rose, F.F. Jr., Mattis, V.B., Rindt, H. and Lorson, C.L. (2009) Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum. Mol. Genet., 18, 997-1005.
43. Sumner, C.J., Wee, C.D., Warsing, L.C., Choe, D.W., Ng, A.S., Lutz, C. and Wagner, K.R. (2009) Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Hum. Mol. Genet., 18, 3145-3152.
44. Eddins, M.J., Marblestone, J.G., Suresh Kumar, K.G., Leach, C.A., Sterner, D.E., Mattern, M.R. and Nicholson, B. (2011) Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy. Cell Biochem. Biophys., 60, 113-118.
45. Sacheck, J.M., Ohtsuka, A., McLary, S.C. and Goldberg, A.L. (2004) IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab., 287, E591-E601.